The Association Between Inflammatory Markers and Obesity-related Factors in Tehranian Adults: Tehran Lipid and Glucose Study

Overview

Journal Iran J Basic Med Sci

Publisher Mashhad University of Medical Sciences

Specialty General Medicine

Date 2014 Nov 26

PMID 25422750

Citations 17

Authors

Bita Faam

Maryam Zarkesh

Maryam Sadat Daneshpour

Fereidoun Azizi

Mehdi Hedayati

Affiliations

Soon will be listed here.

Abstract

Objectives: Obesity considered being a low-grade inflammatory disease. The objective of this study was to examine the association between inflammatory markers (IM) including C-reactive protein (hs-CRP), Interleukin-6 (IL-6), and homocystein (Hcy) and obesity-related factors (e.g. BMI, waist, hip) in adult participants of Tehran lipid and glucose study (TLGS).

Materials And Methods: In this cross-sectional study, 352 individuals (132 men and 220 women), age ≥19 years, were randomly recruited from participants of TLGS population. The serum levels of hs-CRP, IL-6, Hcy were determined using the enzyme linked immunosorbent assay (ELISA) method. Variables were compared by sample t-test. Bivariate linear correlation was estimated using Pearson's correlation coefficient. Linear regression analysis was applied to investigate the association between IMs and anthropometric and biochemical variables.

Results: The mean age of participants was 46.1±16.1 years. abdominal obesity was present in 199(56.5%) individuals. levels of hs-CRP and IL-6 increased in the abdominally obese group (1507±3.3 vs. 577.8±4.3 ng/ml P<0.001) (3.6±3.3 vs. 1.9±3.8 pg/ml P< 0.001), and in the same group, the best predictors for hs-CRP, IL-6 and Hcy were waist (WC), waist to height ratio (WHtR) and wrist respectively; hip and WHtR were the best predictors for Hcy and hs-CRP in the normal group. A linear augmentation in hs-CRP and IL-6 levels was observed in association with obesity categorizes.

Conclusion: This study provides evidence that abdominally obese individuals had higher levels of IMs. Wrist, waist and WHtR were the best predictors for Hcy, hs-CRP and IL-6 respectively in this group.

Citing Articles

Association of resistin rs1862513, rs10401670 and rs3745367 polymorphisms with resistin level and insulin resistance in an Iranian type 2 diabetic population.

Hedayati M, Nezhadali M, Karimi H, Daneshpour M, Najd-Hassan-Bonab L, Sayyar N J Diabetes Metab Disord. 2025; 24(1):38.

PMID: 39801688 PMC: 11711605. DOI: 10.1007/s40200-024-01509-0.

Rizvi A, Rizzo M Medicina (Kaunas). 2024; 60(10).

PMID: 39459434 PMC: 11509678. DOI: 10.3390/medicina60101648.

Predictors of weight and waist gain in US South Asians: Findings from the Mediators of Atherosclerosis in South Asians Living in America (MASALA) study.

Seetharaman S, Allen I, Gadgil M, Srinivasan S, Topor L, Kanaya A Obes Pillars. 2024; 11:100118.

PMID: 39139780 PMC: 11321434. DOI: 10.1016/j.obpill.2024.100118.

Dynamics of Serum Inflammatory Markers and Adipokines in Patients: Implications for Monitoring Abnormal Body Weight: Preliminary Research.

Zimowska M, Rolbiecka M, Antoniak-Pietrynczak K, Jaskulak M, Zorena K Metabolites. 2024; 14(5).

PMID: 38786737 PMC: 11122760. DOI: 10.3390/metabo14050260.

Predictors of weight and waist gain in US South Asians: Findings from the Mediators of Atherosclerosis in South Asians Living in America (MASALA) Study.

Seetharaman S, Allen I, Gadgil M, Srinivasan S, Topor L, Kanaya A Res Sq. 2024; .

PMID: 38585953 PMC: 10996820. DOI: 10.21203/rs.3.rs-4054151/v1.

References

Ridker P . C-reactive protein and the prediction of cardiovascular events among those at intermediate risk: moving an inflammatory hypothesis toward consensus. J Am Coll Cardiol. 2007; 49(21):2129-38. DOI: 10.1016/j.jacc.2007.02.052. View

Ronti T, Lupattelli G, Mannarino E . The endocrine function of adipose tissue: an update. Clin Endocrinol (Oxf). 2006; 64(4):355-65. DOI: 10.1111/j.1365-2265.2006.02474.x. View

Bermudez E, Rifai N, Buring J, Manson J, Ridker P . Interrelationships among circulating interleukin-6, C-reactive protein, and traditional cardiovascular risk factors in women. Arterioscler Thromb Vasc Biol. 2002; 22(10):1668-73. DOI: 10.1161/01.atv.0000029781.31325.66. View

Delavari A, Forouzanfar M, Alikhani S, Sharifian A, Kelishadi R . First nationwide study of the prevalence of the metabolic syndrome and optimal cutoff points of waist circumference in the Middle East: the national survey of risk factors for noncommunicable diseases of Iran. Diabetes Care. 2009; 32(6):1092-7. PMC: 2681035. DOI: 10.2337/dc08-1800. View

FRIEDEWALD W, Levy R, Fredrickson D . Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem. 1972; 18(6):499-502. View

Saijo Y, Kiyota N, Kawasaki Y, Miyazaki Y, Kashimura J, Fukuda M . Relationship between C-reactive protein and visceral adipose tissue in healthy Japanese subjects. Diabetes Obes Metab. 2004; 6(4):249-58. DOI: 10.1111/j.1462-8902.2003.0342.x. View

Yudkin J, Stehouwer C, Emeis J, Coppack S . C-reactive protein in healthy subjects: associations with obesity, insulin resistance, and endothelial dysfunction: a potential role for cytokines originating from adipose tissue?. Arterioscler Thromb Vasc Biol. 1999; 19(4):972-8. DOI: 10.1161/01.atv.19.4.972. View

Trayhurn P, Wood I . Adipokines: inflammation and the pleiotropic role of white adipose tissue. Br J Nutr. 2004; 92(3):347-55. DOI: 10.1079/bjn20041213. View

Dudeja V, Misra A, Pandey R, Devina G, Kumar G, Vikram N . BMI does not accurately predict overweight in Asian Indians in northern India. Br J Nutr. 2001; 86(1):105-12. DOI: 10.1079/bjn2001382. View

10.

OBrien K, Brehm B, Seeley R, Bean J, Wener M, Daniels S . Diet-induced weight loss is associated with decreases in plasma serum amyloid a and C-reactive protein independent of dietary macronutrient composition in obese subjects. J Clin Endocrinol Metab. 2005; 90(4):2244-9. DOI: 10.1210/jc.2004-1011. View

11.

You T, Ryan A, Nicklas B . The metabolic syndrome in obese postmenopausal women: relationship to body composition, visceral fat, and inflammation. J Clin Endocrinol Metab. 2004; 89(11):5517-22. DOI: 10.1210/jc.2004-0480. View

12.

. Obesity: preventing and managing the global epidemic. Report of a WHO consultation. World Health Organ Tech Rep Ser. 2001; 894:i-xii, 1-253. View

13.

Anty R, Bekri S, Luciani N, Saint-Paul M, Dahman M, Iannelli A . The inflammatory C-reactive protein is increased in both liver and adipose tissue in severely obese patients independently from metabolic syndrome, Type 2 diabetes, and NASH. Am J Gastroenterol. 2006; 101(8):1824-33. DOI: 10.1111/j.1572-0241.2006.00724.x. View

14.

Stelzer I, Zelzer S, Raggam R, Pruller F, Truschnig-Wilders M, Meinitzer A . Link between leptin and interleukin-6 levels in the initial phase of obesity related inflammation. Transl Res. 2012; 159(2):118-24. DOI: 10.1016/j.trsl.2011.10.001. View

15.

Vaya A, Rivera L, Hernandez-Mijares A, de la Fuente M, Sola E, Romagnoli M . Homocysteine levels in morbidly obese patients: its association with waist circumference and insulin resistance. Clin Hemorheol Microcirc. 2012; 52(1):49-56. DOI: 10.3233/CH-2012-1544. View

16.

Belfki H, Ben Ali S, Bougatef S, Ahmed D, Haddad N, Jmal A . Relationship of C-reactive protein with components of the metabolic syndrome in a Tunisian population. Eur J Intern Med. 2011; 23(1):e5-9. DOI: 10.1016/j.ejim.2011.10.011. View

17.

Nakamura H, Ito H, Egami Y, Kaji Y, Maruyama T, Koike G . Waist circumference is the main determinant of elevated C-reactive protein in metabolic syndrome. Diabetes Res Clin Pract. 2007; 79(2):330-6. DOI: 10.1016/j.diabres.2007.09.004. View

18.

Ryan A, Nicklas B . Reductions in plasma cytokine levels with weight loss improve insulin sensitivity in overweight and obese postmenopausal women. Diabetes Care. 2004; 27(7):1699-705. DOI: 10.2337/diacare.27.7.1699. View

19.

Klein J, Perwitz N, Kraus D, Fasshauer M . Adipose tissue as source and target for novel therapies. Trends Endocrinol Metab. 2005; 17(1):26-32. DOI: 10.1016/j.tem.2005.11.008. View

20.

Azizi F, Ghanbarian A, Momenan A, Hadaegh F, Mirmiran P, Hedayati M . Prevention of non-communicable disease in a population in nutrition transition: Tehran Lipid and Glucose Study phase II. Trials. 2009; 10:5. PMC: 2656492. DOI: 10.1186/1745-6215-10-5. View